Latest filing published 05 Nov 2010 for Enox Biopharma Inc, €43k.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Itamar David: trading record in brief
Itamar David appears in our data through filings on Enox Biopharma Inc shares, published by SEC (Form 4). We count 3 filings; the first trade dates from 15 July 2010 and the latest from 4 November 2010.
Purchases make up the whole of the open-market record (3 purchases, €128k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
A typical purchase (the median) is worth €43k.
The latest filing, published on 5 November 2010, reports an open-market purchase of €43k in Enox Biopharma Inc. Filings reach the SEC (Form 4) feed a median of 6 days after the trade. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Itamar David
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 201,122 shares@ US$0.30Common StockSEC:0001165527-10-000824:0Canonical exit: 2 Feb 2011 (T+90)
- 201,122 shares@ US$0.30Common StockSEC:0001165527-10-000600:0Canonical exit: 13 Oct 2010 (T+90)
- 25,000 shares@ US$2.00Common StockSEC:0001165527-10-000600:1Canonical exit: 10 Nov 2010 (T+90)
3 of 3 declarations